Biomarkers as Predictors of Suicidal Risk in Adolescents

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Suicide, AttemptedSuicidal IdeationSuicidal IntentionSuicide
Interventions
OTHER

Clinical assessments and blood samples; follow-up for 12 mos

Kiddie-Sads Present and Lifetime Version Diagnostic Interview, Columbia-Suicide Severity Rating Scale, Suicidal Ideation Questionnaire, Children's Depression Rating Scale-Revised, Multidimensional Anxiety Scale for Children (2nd Ed), Adverse Childhood Experiences Questionnaire, Life Events Checklist-5, Pubertal Development Scale. All assessments administered at baseline, and a smaller subset of assessments administered at discharge and other time points throughout 12 months follow-up. Blood samples taken at baseline (admission to unit) and day of discharge.

OTHER

Clinical assessments and blood samples; no 12mo follow-up

Kiddie-Sads Present and Lifetime Version Diagnostic Interview, Columbia-Suicide Severity Rating Scale, Suicidal Ideation Questionnaire, Children's Depression Rating Scale-Revised, Multidimensional Anxiety Scale for Children (2nd Ed), Adverse Childhood Experiences Questionnaire, Life Events Checklist-5, Pubertal Development Scale. All assessments administered at baseline, and a smaller subset of assessments administered at discharge time point (5-7 days after baseline). Blood samples taken at baseline and discharge time points (5-7 days after baseline).

Trial Locations (1)

44195

The Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

Van Andel Research Institute

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

The Cleveland Clinic

OTHER

NCT03014518 - Biomarkers as Predictors of Suicidal Risk in Adolescents | Biotech Hunter | Biotech Hunter